← 產業報告目錄
mRNA Synthesis and Manufacturing Services Market Size, Share & Trends Analysis Report By Type of Industry (Therapeutics/Vaccine Developers, CDMO Organizations, Custom Synthesis/Other Service Providers) By Scale of Operation, By Product and By Application By Region, And by Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-25頁數 269報告編號 INSIGHTACE-f805676dff
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the mRNA Synthesis and Manufacturing Services Market worldwide was assessed at USD 958.52 Million. Analysts project it will advance to USD 2,294.90 Million by 2034, at a CAGR of 7.7% spanning 2025 to 2034. MRNA Synthesis and Manufacturing Services covers reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global mRNA Synthesis and Manufacturing Services Market Snapshot
Chapter 4. Global mRNA Synthesis and Manufacturing Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
4.9. Clinical Trial/Pipeline Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Type of Industry & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Industry:
5.2.1. API
5.2.2. Drug Products
Chapter 5. Market Segmentation 2: By Type of Industry Estimates & Trend Analysis
5.1. By Type of Industry & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Industry:
5.2.1. Therapeutics and Vaccine Developers
5.2.2. CDMO Organizations
5.2.3. Custom Synthesis/cGMP Service Providers
Chapter 6. Market Segmentation 3: By Therapeutic Area Estimates & Trend Analysis
6.1. By Therapeutic Area & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Applications:
6.2.1. Infectious Disease
6.2.2. Oncological Disorders
6.2.3. Others
Chapter 7. Market Segmentation 4: By Scale of Operation Estimates & Trend Analysis
7.1. By Scale of Operation & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Scale of Operation:
7.2.1. Research / Preclinical
7.2.2. Clinical
7.2.3. Commercial
Chapter 8. Market Segmentation 4: By Application Estimates & Trend Analysis
8.1. By Application & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
8.2.1. mRNA-based Vaccines
8.2.2. mRNA-based Therapeutics
Chapter 9. mRNA Synthesis and Manufacturing Services Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.1.2. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.1.3. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.1.4. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.1.5. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.1.6. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. EuropemRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.2.2. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.2.3. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.2.4. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.2.5. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.2.6. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.3.2. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.3.3. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.3.4. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.3.5. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.3.6. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.4.2. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.4.3. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.4.4. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.4.5. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.4.6. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.5.2. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.5.3. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.5.4. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.5.5. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.5.6. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Eurogentec
10.2.2. Aldevron
10.2.3. eTheRNA (Etherna Immunotherapies)
10.2.4. bioSYNTHESIS
10.2.5. TriLink BioTechnologies
10.2.6. Biomay
102.7. Jena Biosciences
10.2.8. APExBIO
10.2.9. CELLSCRIPT
10.2.10. Thermo Fisher Scientific
10.2.11. New England Biolabs
10.2.12. Celonic AG
10.2.13. Corden Pharma GmbH
10.2.14. Lonza Group AG
10.2.15. Rentschler Biopharma
10.2.16. Laboratorios Farmacéuticos Rovi, S.A.
10.2.17. Samsung Biologics
10.2.18. CureVac
10.2.19. Moderna
10.2.20. BioNTech (Pfizer)
10.2.21. Translate Bio
10.2.22. Ethris (AstraZeneca)
10.2.23. Kernal Biologics
10.2.24. Silence Therapeutics
10.2.25. Tiba Biotechnology
10.2.26. In-Cell-Art
10.2.27. Anima Biotech
10.2.28. H3 Biomedicine Inc.
10.2.29. Arcturus Therapeutics
10.2.30. eFFECTOR Therapeutics, Inc.
10.2.31. Ionis Pharmaceuticals, Inc.
10.2.32. Stemirna Therapeutics Co., Ltd.
10.2.33. Skyhawk Therapeutics, Inc.
10.2.34. RNAimmune (Sirnaomics)
10.2.35. Ziphius Therapeutics NV
10.2.36. miRagen Therapeutics, Inc.
10.2.37. Strand Therapeutics Inc.
10.2.38. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們